The Flowr (TSXV:FLWR.H) EBIT : C$-98.84 Mil (TTM As of Sep. 2022)

View and export this data going back to 2017. Start your Free Trial

What is The Flowr EBIT?

The Flowr's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2022 was C$-2.59 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2022 was C$-98.84 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. The Flowr's annualized ROC % for the quarter that ended in Sep. 2022 was -39.09%. The Flowr's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2022 was -40.88%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. The Flowr's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2022 was -525.83%.

The Flowr EBIT Historical Data

The historical data trend for The Flowr's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Flowr EBIT Chart

The Flowr Annual Data

Trend

Jun17

Jun18

Dec19

Dec20

Dec21

EBIT

-0.01

-0.18

-36.94

-129.59

-89.02

The Flowr Quarterly Data
	Sep17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
EBIT	Get a 7-Day Free Trial															-6.71	-72.96	-5.29	-18.01	-2.59

Competitive Comparison of The Flowr's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, The Flowr's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Flowr's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Flowr's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where The Flowr's EV-to-EBIT falls into.

The Flowr EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-98.84 Mil.

The Flowr (TSXV:FLWR.H) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

The Flowr's annualized ROC % for the quarter that ended in Sep. 2022 is calculated as:

	ROC % (Q: Sep. 2022 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2022 )	+	Invested Capital (Q: Sep. 2022 ))	/ count )
=	-11.756 * ( 1 - 0% )	/	( (38.783	+	21.372)	/ 2 )
=	-11.756	/	30.0775
=	-39.09 %

where

	Invested Capital		(Q: Jun. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	50.519	-	10.501	-	( 1.235	-	max(0, 25.353	-	28.685	+	1.235	))
=	38.783

	Invested Capital		(Q: Sep. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	28.538	-	5.687	-	( 1.479	-	max(0, 6.276	-	8.788	+	1.479	))
=	21.372

Note: The Operating Income data used here is four times the quarterly (Sep. 2022) data.

2. Joel Greenblatt's definition of Return on Capital:

The Flowr's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2022 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2022 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2022		Q: Sep. 2022
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-10.34	/	( ( (18.006 + max(14.627, 0))	+	(17.657 + max(0.293, 0)) )	/	2 )
=	-10.34	/	( ( 32.633	+	17.95 )	/	2 )
=	-10.34	/	25.2915
=	-40.88 %

where Working Capital is:

	Working Capital		(Q: Jun. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(2.005	+	3.875	+	19.248)	-	(10.501	+	0	+	0)
=	14.627

	Working Capital		(Q: Sep. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(2.623	+	3.357	+	0)	-	(5.687	+	0	+	0)
=	0.293

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2022) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

The Flowr's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2022 )
	=	-98.84	/	18.797
	=	-525.83 %

The Flowr EBIT Related Terms

Thank you for viewing the detailed overview of The Flowr's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

The Flowr (TSXV:FLWR.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Flowr Corp (TSXV:FLWR.H) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

9590 McCarthy Road, Kelowna, BC, CAN, V4V 1R2

Website

https://www.flowr.ca

The Flowr Corp is a Toronto-headquartered cannabis company with operations in Canada and Europe. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a R&D facility that is awaiting licensing from Health Canada. From this campus, Flowr produces recreational and medicinal products. Internationally, it intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and operates GMP licensed facilities in Portugal.

The Flowr (TSXV:FLWR.H) Headlines

No Headlines